ID: ALA3087814

Max Phase: Preclinical

Molecular Formula: C13H22N2O3S

Molecular Weight: 286.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CCNS(=O)(=O)c1cccc(OC)c1

Standard InChI:  InChI=1S/C13H22N2O3S/c1-4-15(5-2)10-9-14-19(16,17)13-8-6-7-12(11-13)18-3/h6-8,11,14H,4-5,9-10H2,1-3H3

Standard InChI Key:  UWYTYLDQZQFXBP-UHFFFAOYSA-N

Associated Targets(non-human)

Acetylcholinesterase 1323 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 286.40Molecular Weight (Monoisotopic): 286.1351AlogP: 1.32#Rotatable Bonds: 8
Polar Surface Area: 58.64Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.99CX Basic pKa: 8.05CX LogP: 1.29CX LogD: 0.63
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.78Np Likeness Score: -1.91

References

1. Andersson CD, Forsgren N, Akfur C, Allgardsson A, Berg L, Engdahl C, Qian W, Ekström F, Linusson A..  (2013)  Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitors.,  56  (19): [PMID:23984975] [10.1021/jm400990p]

Source